A Bifidobacterial Protein that Can of Reduce Inflammation with COVID-19 and Other Diseases Was Discovered by a RUDN Geneticist (IMAGE)
Caption
A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in COVID-19 patients. A fragment of this protein can be used as an anti-inflammatory medication when treating coronavirus and other diseases.
Credit
RUDN Univeristy
Usage Restrictions
None
License
Licensed content